124-131
FINALPhiladelphia
76ers
54-33|L10: 5-5
New
Orleans Pelicans
50-36|L10: 6-4
-
//
Sports
- All Players
- Seasons
Eastern Conference
Western Conference
More
Sign in
Sign in and connect Sleeper to unlock personalized fantasy insights.
Philadelphia 76ers
New Orleans Pelicans
| # | Team | W-L | Pct | GB |
|---|---|---|---|---|
| 1 | 56-21 | 0.727 |
| Opponent | Date | Result |
|---|---|---|
| 12/9 | L 98-105 | |
| 12/7 |
| — |
| 2 | 54-27 | 0.667 | 4.0 |
| 3 | 49-28 | 0.636 | 7.0 |
| 4 | 48-29 | 0.623 | 8.0 |
| 5 | 47-33 | 0.588 | 10.5 |
| 6 | 42-36 | 0.538 | 14.5 |
| 7 | 43-38 | 0.531 | 15.0 |
| 8 | 43-39 | 0.524 | 15.5 |
| 9 | 38-41 | 0.481 | 19.0 |
| 10 | 60-96 | 0.385 | 35.5 |
| 11 | 28-53 | 0.346 | 30.0 |
| 12 | 26-51 | 0.338 | 30.0 |
| 13 | 24-55 | 0.304 | 33.0 |
| 14 | 24-57 | 0.296 | 34.0 |
| 15 | 0-0 | 0.000 | 17.5 |
| 12/4 | L 101-115 |
| 12/2 | W 108-103 |
| 11/30 | L 97-108 |
| Opponent | Date | Result |
|---|---|---|
| 12/8 | L 109-116 | |
| 12/6 | W 123-114 | |
| 12/4 | L 115-125 | |
| 12/2 | W 123-116 | |
| 12/1 | L 108-114 |
| Player | PointsPPG | FG% | 3P% | FT% |
|---|---|---|---|---|
| 22.8 | 47.7% | 26.8% | 74.4% | |
| 17.3 | 45.9% | 41.0% | 73.4% | |
| 15.7 | 53.2% | 0.0% | 50.4% |
| Player | PointsPPG | FG% | 3P% | FT% |
|---|---|---|---|---|
| 28.5 |
| 24.4% |
| 80.6% |
| 25.6 | 47.5% | 35.8% | 75.1% |
| 19.5 | 48.9% | 30.7% | 61.9% |
| Category | NOP Offense | PHI Defense | Advantage |
|---|---|---|---|
Offensive RatingPoints scored per 100 possessions | #692.4 ORtg | #2102.8 DRtg | PHI |
Turnover RateLower offensive turnovers vs defensive forced turnovers | #2212.0% | #2013.3% | Even |
3P% vs AllowedPerimeter efficiency vs perimeter defense | #1336.4% | #434.6% | PHI |
| Category | NOP Defense | PHI Offense | Advantage |
|---|---|---|---|
Offensive RatingPoints allowed per 100 possessions | #13106.1 DRtg | #2087.7 ORtg | PHI |
Turnover RateDefensive takeaways vs offensive giveaways | #2113.3% | #2912.9% | NOP |
3P% vs AllowedPerimeter defense vs perimeter shooting | #735.0% | #1436.3% | PHI |
